1 The mechanisms responsible for cholesterol accumulation in cells are not fully understood. While most cells have on their surface a specific receptor for apolipoprotein (apo) B and apo E-containing lipoproteins [the low density lipoprotein (LDL) receptor 23 ], the activity of this receptor is inversely proportional to the cholesterol level in cells. 45 Thus, when the cell cholesterol level is increased, the activity of the LDL-receptor is decreased. Hence, it is unlikely that LDL receptor-mediated uptake of LDL can account solely for the observed cholesterol
T he accumulation of cholesterol and cholesteryl esters in arterial wall cells is an early event during atherogenesis. 1 The mechanisms responsible for cholesterol accumulation in cells are not fully understood. While most cells have on their surface a specific receptor for apolipoprotein (apo) B and apo E-containing lipoproteins [the low density lipoprotein (LDL) receptor 23 ], the activity of this receptor is inversely proportional to the cholesterol level in cells. 45 Thus, when the cell cholesterol level is increased, the activity of the LDL-receptor is decreased. Hence, it is unlikely that LDL receptor-mediated uptake of LDL can account solely for the observed cholesterol accumulation in cells exposed to high concentrations of apo B-or apo E-containing lipoproteins. 6 -9 Macrophages have scavenger receptors that bind and take up several modified forms of lipoproteins, leading to massive cholesterol accumulation and foam cell formation. 10 However, arterial smooth muscle cells lack scavenger receptors. 10 Thus, receptor-independent mechanisms are likely to contribute to the observable accumulation of cholesterol mass in arterial smooth muscle cells exposed to high levels of LDL. Accumulation of cholesterol by LDL receptor-independent mechanisms could, in part, be explained by surface transfer of free cholesterol from lipoproteins to cells followed by subsequent esterification. The plausibility of such a transfer and esterification process has been demonstrated in cell culture studies by using a variety of different cell types and extracellular cholesterol donor particles. 6 -911 - 19 In this study, the ability of arterial smooth muscle cells to accumulate cholesterol after exposure to LDL at concentrations sufficient to express the LDL receptor was examined. Further, the hypothesis that surface transfer of unesterified cholesterol between LDL and arterial smooth muscle cells can contribute to a mass accumulation of cholesterol in the cells was tested directly. Arterial smooth muscle cells from the nonhuman primate, Macaca nemestrina, were exposed to high concentrations of LDL labeled either with 125 I in the protein moiety, with 3 H-cholesterol in the particle surface, or with 3 H-cholesteryl linoleyl ether ( 3 H-CLE) in the lipid core of the particle. The extent to which the cellular free and esterified cholesterol content increased and the degree to which the accumulation of cholesterol mass in the cells could be accounted for by LDL particle uptake, by exchange of LDL free 3 H-cholesterol, and by LDL cholesteryl ester uptake was determined.
Methods

Materials
3 H-cholesterol (55 Ci/mmol) was obtained from Du Pont-New England Nuclear (Boston, MA) and proved to be greater than 98% pure. 3 H-cholesteryl linoleyl ether was synthesized from 3 H-cholesterol and linoleyl alcohol (Sigma, St. Louis, MO), as described by Halperin and Gatt. 20 The compound 58-035 [3-decyldimethylsilyl-A/-2-(4-methylphenyl)-1-phenylethyl propanamide], an inhibitor of the enzyme acyl-CoA:cholesterol acyltransferase (ACAT), was generously provided by Sandoz Incorporated (East Hanover, NJ). Cell culture media and supplements were obtained from Gibco (Grand Island, NY). Cholesterol oxidase was obtained from Calbiochem (San Diego, CA).
Cell Culture
Arterial smooth muscle cells were derived from intimamedial explants of monkey (Macaca nemestrina) thoracic artery. 21 The cells were cultivated in Dulbecco's modified Eagle's medium (DMEM) with 10% calf serum. For experiments, cells were seeded either in 16 mm diameter cell culture wells or in 35 mm diameter cell culture dishes. The growth medium was replaced with fresh medium every third day (0.5 ml growth medium/ well or 1.0 ml/dish), and the cells became confluent within 5 to 7 days. Then cells were kept for 3 days in DMEM supplemented with 0.2% calf serum to render them quiescent. The cell number ceased to increase after 2 to 3 days in this low-serum medium.
Lipoproteins LDL (d=1.019 to 1.063 g/ml) were prepared from human plasma (EDTA 4 mM) by vertical rotor ultracentrifugation 22 followed by standard sequential gradient ultracentrifugation. 5 The LDL stock solution (about 11 to 15 mg/ml) was stored under N 2 in the dark at 4°C until used within 2 weeks of preparation. Lipoproteindeficient serum was prepared by ultracentrifugation at d=1.25 g/ml. 23 Radio-iodination of LDL was performed with the iodine monochloride method as modified for lipoproteins. 24 The 25 The final specific activity was 10 to 15 cpm/nmol LDL cholesteryl ester, assuming complete mixing of the 3 H-cholesteryl linoleyl ether with cholesteryl esters of the LDL particle core.
Incubation Procedure
Confluent and quiescent smooth muscle cells were incubated for 48 hours (unless otherwise indicated) in DMEM with 0.2% calf serum supplemented with LDL (0.5 mg protein/ml, unless otherwise indicated).
The LDL used was native LDL, or native LDL labeled with either 125 I, 3 H-cholesterol, or 3 H-cholesteryl linoleyl ether for measurement of particle uptake, exchange of unesterified cholesterol, or LDL cholesteryl ester uptake, respectively. Some cells were also exposed to 5 ^.g/ml of the ACAT-inhibitor compound 58-035 (added from an ethanolic stock solution, final ethanol concentration <0.1 % vol/vol). Control cells run in parallel received 0.2% calf serum alone, with appropriate amounts of ethanol. The complete incubation medium also contained 0.1 fiM butylated hydroxytoluene as anti-oxidant. When cells were exposed to LDL for longer than 48 hours, the incubation medium was replaced every 48 hours. At the completion of the experiments, the media were removed (and saved when necessary), and the cell monolayers were washed five times with phosphate-buffered saline (PBS, pH 7.4). The cells were stored at -20°C until further processed within 4 days. Cellular uptake of either 3 H-cholesterol or 3 H-cholesteryl linoleyl ether, and cellular formation of 3 H-cholesteryl ester was determined from the neutral lipid extract, as described under lipid analysis.
Uptake and Degradation of 125 I-LOW Density Lipoprotein
To determine the extent of lipoprotein degradation, confluent and quiescent monkey arterial smooth muscle cells were incubated with 0.5 mg/ml 125 I-LDL (final specific activity 10 to 20 cpm/ng LDL protein) in DMEM containing 0.2% calf serum for 48 hours. At the completion of the incubation, a sample of the incubation medium was taken for measurement of 125 I-LDL degradation products. 26 Degradation of 125 I-LDL was measured in parallel in cell-free dishes, and was subtracted from total degradation to give a measure of LDL that was degraded by cells. Degradation of 12S I-LDL in the absence of cells was usually less than 2% of the total amount degraded by cells.
After collection of incubation media, cell monolayers were washed five times with PBS, lipids were extracted, and the proteins were digested into 0.1 N NaOH. Aliquots were taken for counting of cellular 125 l-radioactivity (cellretained, undegraded 125 I-LDL), and for protein determination 27 using bovine serum albumin as standard.
Oxidation of Cell Surface 3 H-Cholesterol
To measure the extent of cholesterol exchange between LDL and the cell surface (i.e., plasma membrane), cholesterol oxidase was used to probe the distribution of cholesterol between the plasma membrane and intracellular membranes. 2829 Before the experiments, cells were pretreated for 24 hours with either DMEM with 0.2% calf serum or the same medium supplemented with unlabeled LDL (0.5 mg protein/ml). Cells in 35 mm dishes were then incubated with 3 H-cholesterol-labeled LDL (0.5 mg protein/ ml) for up to 4 hours. Cells were then washed three times with PBS at 4°C and incubated with dextran sulphate (4 mg/ml in PBS) for 10 minutes at 4°C to dissociate LDL from the LDL receptor. 23 After three further washes with PBS, the cells were fixed with glutaraldehyde (1 % vol/vol in PBS) for 10 minutes at 4°C. Excess glutaraldehyde was removed with three additional washes, and 1 ml PBS at 37°C was added to each dish together with 1 U of cholesterol oxidase. The cells were exposed to the cholesterol oxidase for exactly 10 minutes at 37°C. Cells were then washed once with ice-cold PBS and immediately frozen (-20°C).
Lipid Analysis
Cellular neutral lipids were extracted with hexane/ isopropanol (3:2 vol/vol) 30 containing butylated hydroxytoluene (50 pM) as an anti-oxidant. Cholesterol, 3 H-cholesterol, 3 H-cholestenone, cholesteryl esters, and 3 H-cholesteryl esters were isolated on either Silica Gel H (for cholesterol mass analysis) or Silica Gel G (for scintillation counting) thin-layer chromatography plates (Analtech, Newark, NJ) and were eluted with hexane/diethyl ether/acetic acid (130:40:1.5) (vol/vol/vol). Sterol mass was determined from extracts of the appropriate spots on the thin-layer chromatogram by the cholesterol oxidase method. 31 The radioactivity in the free and esterified cholesterol spots was determined by counting an aliquot of the chromatogram extracts.
Results
Cellular Uptake of Cholesterol from Low Density Lipoprotein and Accumulation of Cholesterol Mass
Cultured cells exposed to high levels of LDL have been shown to accumulate free and esterified cholesterol mass. 91932 To determine the extent of cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells, confluent and quiescent cells were exposed to varying amounts of LDL for 4 days. An accumulation of both free and esterified cholesterol in cells exposed to LDL was observed (Figure 1 ). The extent of cholesteryl ester accumulation was proportional to the concentration of LDL in the incubation medium, whereas the increase in cellular free cholesterol mass was maximal at 50 ^9 protein/ml and did not increase further with higher LDL concentrations. An LDL concentration of 0.5 mg LDL protein/ml was used in subsequent studies, since it resulted in marked elevations of cellular cholesterol content. 
Contribution of Endogenous Esterification to Cellular Accumulation of Cholesteryl Ester Mass in Cells Exposed to Low Density Lipoprotein
To determine the role of endogenous esterification of cholesterol by ACAT to the observable accumulation of cholesteryl ester mass in smooth muscle cells exposed to LDL, cells were incubated with 3 H-cholesterol LDL and the uptake and esterification of 3 H-cholesterol was determined in cells treated with or without the ACAT-inhibitor, Sandoz compound 58-035.
3334 Cells were exposed to 0.5 mg/ml of 3 H-cholesterol-LDL for up to 96 hours in the presence or absence of compound 58-035 at 5 ^g/ml. The arterial smooth muscle cells incorporated LDL-derived free 3 H-cholesterol readily, and at the end of the 96-hour incubation period, more than 90% of the cellular free cholesterol had been exchanged with 3 H-cholesterol from LDL ( Figure 2 ). Cells that were not exposed to compound 58-035 had esterified about 13% of the incorporated 3 H-cholesterol at the end of the 96-hour incubation (Figure 2A ). Cells treated with 5 ptg/ml of compound 58-035 incorporated LDL-derived 3 H-cholesterol to the same extent as untreated cells, but the subsequent esterification of 3 H-cholesterol was completely blocked ( Figure 2B ). These results confirm that compound 58-035 at 5 /xg/ml also is a potent inhibitor of ACAT in monkey arterial smooth muscle cells.
In addition to uptake and esterification of LDL-derived cholesteryl ester mass continued to increase during the incubation period (Figure 2A ). The accumulation of cholesteryl ester mass in cells treated with compound 58-035 was about one-third lower ( Figure 2B ) than the level found in untreated cells (Figure 2A ). In general, the accumulation of cholesteryl ester mass in cells exposed to the ACAT inhibitor was about 40% [average from five separate experiments (range 25% to 50%)] less than in control cells. Hence it appears that a maximum of 50% of the accumulated cholesteryl ester mass was derived from endogenous synthesis of cholesteryl esters, i.e., was due to the ACATreaction that could be blocked by compound 58-035. Exogenous cholesterol available to the ACAT reaction could be derived from uptake and degradation of LDL, or from surface transfer of free cholesterol between LDL and cells. The remainder of the accumulated cholesteryl esters must have been derived from uptake and retention of LDL cholesteryl esters without lysosomal hydrolysis. (Table 1) . Based on the lipid composition of the 125 I-LDL (2.1 nmol cholesteryl ester and 1.0 nmol unesterified cholesterol//^g LDL protein), it can be calculated that these cells internalized a maximum of 64.0 nmol (controls) and 63.7 nmol (cells treated with compound 58-035) total sterol/mg cell protein, respectively (total sterol=sum of LDL free and esterified cholesterol). However, the increase in cell sterol mass (total sterol in LDL-treated cells minus total sterol in cells grown in 0.2% calf serum only) was 115 nmol/mg cell protein for control cells and 96.4 nmol/mg in cells treated with compound 58-035. Hence, a substantial amount (about 44% and 34% for control cells and 58-035-treated cells, respectively) of the accumulated cell sterol mass could not be accounted for by LDL particle uptake and degradation. Also, whereas cells incubated with the ACAT inhibitor internalized and degraded equal amounts of 125 I-LDL compared to control cells, they accumulated only one-half to three-quarters the cholesteryl ester mass of untreated cells ( Table 1 ). The accumulation of unesterified cholesterol was about the same in the two treatment groups. To further examine the relationship between LDL lipid that was internalized and the actual mass of sterol that accumulated intracellularly, the uptake of the cholesteryl ester moiety of LDL was traced with 3 H-cholesteryl linoleyl ether.
Cellular Uptake and
Cholesteryl Ester Mass Accumulation in Cells Treated with 3 H-Cholesteryl Linoleyl Ether-containing Low Density Lipoprotein
3
H-cholesteryl linoleyl ether is a nondegradable marker for cholesteryl esters. Uptake of this tracer is representative of cholesteryl ester uptake, since it is not degraded but, instead, accumulates in cells. 253536 Radiolabeled cholesteryl linoleyl ether has been used to accurately measure the internalization of lipoprotein-derived cholesteryl esters. 353637 Confluent and quiescent smooth muscle cells were exposed for 48 hours to 0.5 mg protein/ ml of LDL containing trace amounts of 3 H-cholesteryl linoleyl ether ( 3 H-CLE-LDL), and the subsequent cellular accumulation of 3 H-CLE-LDL tracer and sterol mass was determined. Under these incubation conditions, smooth muscle cells internalized 49 and 47 nmol total LDLderived sterol/mg cell protein when incubated in the absence or presence of compound 58-035 (Table 2) . These values are calculated from the internalization of the nondegradable 
H-Cholesteryl Linoleyl Ether-labeled Low Density Lipoproteins
Sterol uptake based Cell sterol mass* Net sterol increase* on pound 58-035-treated cells, respectively (Table 2) . Thus, about 39% and 47% (control cells and 58-035-treated cells, respectively) of the accumulated total sterol mass could not be accounted for by the calculated internalization of LDL particles.
Since LDL-derived free cholesterol is readily exchangeable with cell cholesterol (Figure 2 ), it appears that the discrepancy in the amounts of actual cell sterol accumulation and the amount of LDL sterol uptake after LDL particle internalization could, in part, be due to additional surface transfer of LDL free cholesterol to the cells. To further test for this possibility, the distribution of LDLderived free 3 H-cholesterol between the cell surface and intracellular pools was determined.
Distribution of LDL Free 3 H-Cholesterol between Cholesterol Oxidase-Susceptible and -Resistant Pools
Cholesterol oxidase has successfully been used to probe the localization of cell cholesterol between the cell surface or plasma membrane (oxidase-susceptible) and intracellular compartments (oxidase-resistant). 2829 This approach was used to examine the distribution of LDL-derived free 3 H-cholesterol between the cell surface (the site of exchange with lipoproteins) and the intracellular compartments (i.e., the endosomes and lysosomes where LDL is trapped after internalization). Confluent and quiescent smooth muscle cells that had been pretreated for 48 hours with either DMEM (0.2% calf serum) alone or the same medium containing 0.5 mg/ml of LDL protein (to down-regulate the LDL receptor) were exposed to 0.5 mg protein/ml of One major focus of the present study was to elucidate the potential mechanisms by which arterial smooth muscle cells accumulate cholesterol, with particular reference to the role of cholesterol surface transfer between LDL and cells. By comparing the accumulation of cholesterol mass in cells on one hand, and the uptake and degradation of 125 I-LDL on the other, it was found that cells exposed to high concentrations of 125 I-LDL (0.5 mg LDL protein/ml, corresponding to 1.55 mmol/l total sterol) accumulated more cholesterol mass (both free and esterified) than could be accounted for by 125 I-LDL particle uptake alone (sum of 125 l-degradation products and cellassociated 125 l-activity). Under the experimental conditions used, about 60% of the accumulated cholesterol mass was derived from 125 I-LDL particle uptake, whereas the rest (i.e., 40%) derived from LDL, but was taken up into cells independent of LDL particle uptake or apolipoprotein uptake and degradation.
Additional evidence for cholesterol uptake into cells independent of LDL particle uptake was obtained from studies where the cellular metabolism of 3 H-cholesteryl linoleate ether-labeled LDL was examined. When the uptake of LDL-derived 3 H-cholesteryl linoleyl ether was quantified, it was found that only about 60% of the accumulated cholesterol mass in the cells could be accounted for by uptake of LDL particles. The calculation of this percentage was based on the assumption that uptake of 3 H-cholesteryl linoleyl ether was accompanied by LDL particle uptake. Recently it has been shown that cholesteryl esters in high density lipoprotein can enter cells independent of particle uptake.
404142 Potential mechanisms for selective uptake of cholesteryl esters independent of particle uptake include preferential transfer of lipid into cells or lipid release during retroendocytosis of lipoproteins. 2643 If analogous mechanisms led to the cellular uptake of 3 H-cholesteryl linoleyl ether from LDL observed in the present study, then the proportion of cholesterol that accumulated independent of LDL particle uptake would be even greater than that calculated. Use of an inhibitor of ACAT reduced the accumulation of cholesteryl ester mass by 40%, suggesting that a significant proportion of the cholesteryl ester mass that accumulated from LDL did so without being hydrolyzed and reesterified. It is conceivable that LDL cholesteryl ester delivered to cells by such mechanisms could accumulate without undergoing lysosomal hydrolysis and without downregulating the LDL receptor, leading to foam cell formation.
Since more cholesterol mass accumulates in cells exposed to LDL than can be accounted for by LDL particle uptake, additional mechanisms that promote transfer of LDL cholesterol to cells independent of LDL particle or apolipoprotein uptake must exist. The most plausible process involves the surface transfer of unesterified cholesterol from LDL particles to cell membranes. Cholesterol in lipoproteins can exchange readily with cholesterol in other lipoprotein particles 4445 and with cholesterol in cells such as adipocytes 46 and hepatocytes. 1847 If the cholesterol-to-phospholipid molar ratio in the donor particles (e.g., LDL) exceeds that in the acceptor structure (e.g., cell membranes) the exchange process will lead to a net transfer of cholesterol between donor and acceptor to equilibrate the apparent concentration gradient.
1118
This mechanism could lead to a net transfer of free cholesterol from LDL to the cell surface and subsequent incorporation intracellularly. Delivery of free cholesterol to cells without degradation of LDL also could occur during retroendocytosis.
264348
Consistent with previous studies, incubation of smooth muscle cells with LDL containing trace amounts of free 3 H-cholesterol led to a rapid cellular uptake of the 3 H-cholesterol from LDL. 7 -12 Whereas some of the cellassociated 3 H-cholesterol was derived from LDL particle uptake, most of it was transferred from LDL to cells by surface transfer independent of particle uptake. The cellassociated 3 H-cholesterol was distributed evenly between the cell surface (cholesterol oxidase-susceptible) and the cell interior (oxidase-resistant) after the first hour of exposure. With time, however, the fraction of 3 H-cholesterol in the oxidase-susceptible pool diminished, whereas the fraction of 3 H-cholesterol in the oxidase-resistant pool increased. The state of LDL receptor activity affected the distribution of 3 H-cholesterol between the oxidase susceptible and resistant pools. With "normal" LDL receptor activity and cellular intemalization of LDL, a large fraction of the LDL-derived 3 H-cholesterol was resistant to oxidation by cholesterol oxidase, suggesting it was located mainly inside the cells (most likely in endosomes and lysosomes). However, in cells pretreated with LDL to down-regulate LDL receptor activity and thus decrease the rate of receptor-mediated LDL particle intemalization, a substantially smaller fraction of the cell associated 3 H-cholesterol was oxidase-resistant, presumably in the cell interior.
The results of this study show that when cells are exposed to large amounts of LDL, the accumulation of cell cholesterol cannot be totally accounted for by LDL particle uptake (either receptor-mediated or nonspecific uptake). It appears that surface transfer of LDL free cholesterol into cells contributes significantly to the cellular sterol mass accumulation seen in this in vitro model. It also is likely that surface transfer of free cholesterol from LDL to vascular cells plays a significant role for cholesterol accumulation in vivo. It has been reported that lipoproteins (both very low density lipoprotein and LDL) from patients with increased risk for atherosclerosis show a consistent increase in their free cholesterol content. 49 - 52 The surface film of these particles appears to be almost completely saturated with cholesterol. 5354 Of interest in this regard, an increased plasma unesterified cholesterol-to-phospholipid ratio has been associated with atherosclerosis in humans 55 and atheroma development in mice. 56 Surface transfer of free cholesterol between lipoproteins and cells is a physicochemical process that is not subject to the same kind of metabolic regulation seen with the LDL receptor pathway, but instead is dependent on the saturation of cholesterol in lipoprotein particles. Therefore, surface transfer of cholesterol is likely to be of major importance as a mechanism for cholesterol accumulation in arterial cells of patients with a high cholesterol saturation in lipoproteins (such as those with noninsulin-dependent diabetes 52 ) and with high circulating concentrations of LDL.
